8 months ago
SANA
AnalystsEmily BodnarEmily Bodnar's Stock Forecasts
AnalystsEmily Bodnar
Sectors:
Analyst Ranking
Bottom 1%
#5011 out of 5014 analysts
Average Return
-17.39%
Win Rate
28%83 out of 299
Risk vs Reward
Poor
Good
Emily Bodnar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gracell Biotechnologies IncGRCL | +372.38% | $2.10 | $9.92 | 2023-02-16 - 2023-12-26 | Buy |
Gracell Biotechnologies IncGRCL | +322.13% | $2.35 | $9.92 | 2023-02-06 - 2023-12-26 | Buy |
Mink Therapeutics IncINKT | +313.74% | $6.77 | $28.01 | 2024-10-09 - 2025-07-15 | Buy |
Mink Therapeutics IncINKT | +271.49% | $7.54 | $28.01 | 2024-11-15 - 2025-07-15 | Buy |
Gracell Biotechnologies IncGRCL | +254.29% | $2.80 | $9.92 | 2023-05-26 - 2023-12-26 | Buy |
Emily Bodnar Analyst Color
Get additional color on Emily Bodnar's coverage of popular stocks
2 years ago
FEMY
Emily Bodnar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Agenus IncAGEN | 14 | Buy | $23.00 | +413.39% | Reiterates | 4 days ago |
Agios Pharmaceuticals IncAGIO | 2 | Buy | $56.00 | +52.26% | Reiterates | 10 days ago |
Briacell Therapeutics CorpBCTX | 15 | Buy | $40.00 | +400.00% | Maintains | 18 days ago |
Mink Therapeutics IncINKT | 14 | Buy | $35.00 | +143.06% | Upgrades | a month ago |
Vtv Therapeutics IncVTVT | 2 | Buy | $36.00 | +82.19% | Reiterates | a month ago |
Femasys IncFEMY | 25 | Buy | $8.00 | +1,940.82% | Maintains | a month ago |
Context Therapeutics IncCNTX | 10 | Buy | $4.00 | +379.04% | Maintains | a month ago |
Sab Biotherapeutics IncSABS | 2 | Buy | $9.00 | +324.53% | Maintains | 2 months ago |
Rapt Therapeutics IncRAPT | 2 | Buy | $27.00 | +66.46% | Maintains | 2 months ago |
Jasper Therapeutics IncJSPR | 10 | Buy | $20.00 | +723.05% | Maintains | 2 months ago |
Nextcure IncNXTC | 9 | Buy | $36.00 | +567.16% | Reiterates | 2 months ago |
Arcellx IncACLX | 13 | Buy | $115.00 | +50.94% | Reiterates | 3 months ago |
Artiva Biotherapeutics IncARTV | 1 | Buy | $12.00 | +370.59% | Assumes | 3 months ago |
Anaptysbio IncANAB | 9 | Buy | $38.00 | +62.39% | Upgrades | 3 months ago |
Olema Pharmaceuticals IncOLMA | 19 | Buy | $30.00 | +286.10% | Reiterates | 5 months ago |
Sana Biotechnology IncSANA | 10 | Buy | $11.00 | +241.61% | Reiterates | 5 months ago |
Transcode Therapeutics IncRNAZ | 17 | Buy | $280.00 | +2,516.82% | Maintains | 5 months ago |
Connect Biopharma Holdings LtdCNTB | 6 | Buy | $8.00 | +412.82% | Reiterates | 5 months ago |
Io Biotech IncIOBT | 13 | Buy | $12.00 | +476.92% | Reiterates | 5 months ago |
Genelux CorpGNLX | 7 | Buy | $30.00 | +659.49% | Reiterates | 5 months ago |
Acrivon Therapeutics IncACRV | 11 | Buy | $19.00 | +1,150.00% | Reiterates | 6 months ago |
Nkarta IncNKTX | 13 | Buy | $18.00 | +813.71% | Reiterates | 6 months ago |
Imunon IncIMNN | 13 | Buy | $210.00 | +3,552.17% | Reiterates | 6 months ago |
Atossa Therapeutics IncATOS | 13 | Buy | $7.00 | +733.33% | Reiterates | 6 months ago |
Arcus Biosciences IncRCUS | 5 | Buy | $24.00 | +108.33% | Upgrades | 7 months ago |
Tenaya Therapeutics IncTNYA | 1 | Buy | $18.00 | +1,400.00% | Reiterates | 7 months ago |
Novocure LtdNVCR | 18 | Buy | $38.00 | +212.76% | Reiterates | 8 months ago |
Acelyrin IncSLRN | 13 | Hold | $6.00 | +164.32% | Maintains | 8 months ago |
Geron CorpGERN | 3 | Buy | $9.00 | +608.66% | Reiterates | 9 months ago |
Purple Biotech LtdPPBT | 13 | Buy | $33.00 | +5,679.33% | Reiterates | 10 months ago |
Ventyx Biosciences IncVTYX | 13 | Hold | $6.00 | +160.87% | Reiterates | 10 months ago |
Gracell Biotechnologies IncGRCL | 6 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Dice Therapeutics IncDICE | 8 | Hold | $48.00 | N/A | Reiterates | 2 years ago |
Sqz Biotechnologies CoSQZB | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.